Afdn showed a log2 value of 9.33 with a q-value of 0.025, suggesting a moderate increase in expression, and Cldn2 displayed a substantial negative log2 value (−23.34) with a significant q-value (1.44 × 10−7), indicating a decrease in its transcript following BC treatment. Here, CLDN2 is linked to breast cancer.